Drug companies have been required since 1 January to record any payments to doctors with a view to this becoming publicly searchable knowledge from July 2016. Writing in NLJ this week, Leigh Day solicitor Sarah Moore says the new code aims to encourage transparency, but she questions how successful the initiative will be. Doctors can formally opt out, she notes, while neither private hospitals nor medical device companies are covered by the requirement. Most crucially, she says, the code is voluntary.
13 February 2015
Medical transparency?
MOVERS & SHAKERS
Bellevue Law—Sara Mason
Bellevue Law expands workplace law offering with specialist healthcare regulatory appointment
Seddons GSC—Peter Ames
Seddons GSC strengthens Dispute Resolution team with partner hire
Taylor Rose—four promotions
Taylor Rose announces partner promotions
NEWS
Pressure is mounting for a dedicated UK AI law, but deciding what it should achieve remains the central challenge
Legal professional privilege has checked the SRA’s investigative powers, exposing difficult questions about tackling suspected abusive litigation
Refusing mediation need not trigger a costs penalty, but litigators must justify their position
Group claims, disputed costs and judicial recruitment dominate the latest courtroom round-up
Landlords face fresh registration duties as procedural reforms reshape the civil courts
Copyright © 2026 LexisNexis
